Toll-like  ||| S:0 E:10 ||| JJ
receptor  ||| S:10 E:19 ||| NN
4  ||| S:19 E:21 ||| CD
mediates  ||| S:21 E:30 ||| CD
the  ||| S:30 E:34 ||| DT
antitumor  ||| S:34 E:44 ||| JJ
host  ||| S:44 E:49 ||| NN
response  ||| S:49 E:58 ||| NN
induced  ||| S:58 E:66 ||| NN
by  ||| S:66 E:69 ||| IN
Ganoderma  ||| S:69 E:79 ||| NNP
atrum  ||| S:79 E:85 ||| VBZ
polysaccharide  ||| S:85 E:100 ||| VBG
The  ||| S:100 E:104 ||| DT
aim  ||| S:104 E:108 ||| NN
of  ||| S:108 E:111 ||| IN
this  ||| S:111 E:116 ||| DT
study  ||| S:116 E:122 ||| NN
is  ||| S:122 E:125 ||| VBZ
to  ||| S:125 E:128 ||| TO
investigate  ||| S:128 E:140 ||| VB
the  ||| S:140 E:144 ||| DT
role  ||| S:144 E:149 ||| NN
of  ||| S:149 E:152 ||| IN
Toll-like  ||| S:152 E:162 ||| JJ
receptor  ||| S:162 E:171 ||| NN
( ||| S:171 E:172 ||| -LRB-
TLR ||| S:172 E:175 ||| NNP
)  ||| S:175 E:177 ||| -RRB-
4  ||| S:177 E:179 ||| CD
in  ||| S:179 E:182 ||| IN
Ganoderma  ||| S:182 E:192 ||| NNP
atrum  ||| S:192 E:198 ||| FW
polysaccharide  ||| S:198 E:213 ||| FW
( ||| S:213 E:214 ||| -LRB-
PSG-1 ||| S:214 E:219 ||| NNP
) ||| S:219 E:220 ||| -RRB-
-induced  ||| S:220 E:229 ||| JJ
antitumor  ||| S:229 E:239 ||| JJ
activity ||| S:239 E:247 ||| NN
.  ||| S:247 E:249 ||| .
In  ||| S:249 E:252 ||| IN
vitro ||| S:252 E:257 ||| NN
,  ||| S:257 E:259 ||| ,
the  ||| S:259 E:263 ||| DT
apoptosis  ||| S:263 E:273 ||| JJ
rate  ||| S:273 E:278 ||| NN
of  ||| S:278 E:281 ||| IN
S-180  ||| S:281 E:287 ||| CD
cells  ||| S:287 E:293 ||| NNS
was  ||| S:293 E:297 ||| VBD
increased  ||| S:297 E:307 ||| VBN
in  ||| S:307 E:310 ||| IN
PSG-1-induced  ||| S:310 E:324 ||| CD
peritoneal  ||| S:324 E:335 ||| NNS
macrophage  ||| S:335 E:346 ||| VBP
derived  ||| S:346 E:354 ||| VBN
from  ||| S:354 E:359 ||| IN
C3H ||| S:359 E:362 ||| NNP
/ ||| S:362 E:363 ||| NNP
HeN  ||| S:363 E:367 ||| NNP
( ||| S:367 E:368 ||| -LRB-
wild-type ||| S:368 E:377 ||| NNP
)  ||| S:377 E:379 ||| -RRB-
mice ||| S:379 E:383 ||| NNS
,  ||| S:383 E:385 ||| ,
but  ||| S:385 E:389 ||| CC
not  ||| S:389 E:393 ||| RB
from  ||| S:393 E:398 ||| IN
C3H ||| S:398 E:401 ||| NNP
/ ||| S:401 E:402 ||| NNP
HeJ  ||| S:402 E:406 ||| NNP
( ||| S:406 E:407 ||| -LRB-
TLR4-deficient ||| S:407 E:421 ||| NNP
)  ||| S:421 E:423 ||| -RRB-
mice ||| S:423 E:427 ||| NNS
.  ||| S:427 E:429 ||| .
In  ||| S:429 E:432 ||| IN
the  ||| S:432 E:436 ||| DT
S-180  ||| S:436 E:442 ||| JJ
tumor  ||| S:442 E:448 ||| NN
model ||| S:448 E:453 ||| NN
,  ||| S:453 E:455 ||| ,
phagocytosis ||| S:455 E:467 ||| NN
,  ||| S:467 E:469 ||| ,
NO  ||| S:469 E:472 ||| RB
and  ||| S:472 E:476 ||| CC
ROS  ||| S:476 E:480 ||| NNP
release ||| S:480 E:487 ||| NN
,  ||| S:487 E:489 ||| ,
phosphorylation  ||| S:489 E:505 ||| VBG
of  ||| S:505 E:508 ||| IN
MAPKs  ||| S:508 E:514 ||| JJ
and  ||| S:514 E:518 ||| CC
Akt ||| S:518 E:521 ||| NNP
,  ||| S:521 E:523 ||| ,
and  ||| S:523 E:527 ||| CC
expression  ||| S:527 E:538 ||| NN
of  ||| S:538 E:541 ||| IN
NF-ÎºB  ||| S:541 E:547 ||| NNP
were  ||| S:547 E:552 ||| VBD
increased  ||| S:552 E:562 ||| VBN
by  ||| S:562 E:565 ||| IN
PSG-1  ||| S:565 E:571 ||| CD
in  ||| S:571 E:574 ||| IN
peritoneal  ||| S:574 E:585 ||| JJ
macrophage  ||| S:585 E:596 ||| NNS
derived  ||| S:596 E:604 ||| VBN
from  ||| S:604 E:609 ||| IN
C3H ||| S:609 E:612 ||| CD
/ ||| S:612 E:613 ||| CD
HeN  ||| S:613 E:617 ||| JJ
mice ||| S:617 E:621 ||| NNS
.  ||| S:621 E:623 ||| .
Furthermore ||| S:623 E:634 ||| RB
,  ||| S:634 E:636 ||| ,
PSG-1  ||| S:636 E:642 ||| NNP
elevated  ||| S:642 E:651 ||| VBD
Th1  ||| S:651 E:655 ||| CD
cytokine  ||| S:655 E:664 ||| JJ
production  ||| S:664 E:675 ||| NN
and  ||| S:675 E:679 ||| CC
enhanced  ||| S:679 E:688 ||| VBN
the  ||| S:688 E:692 ||| DT
cytotoxic  ||| S:692 E:702 ||| JJ
activity  ||| S:702 E:711 ||| NN
of  ||| S:711 E:714 ||| IN
CTL  ||| S:714 E:718 ||| NNP
and  ||| S:718 E:722 ||| CC
NK  ||| S:722 E:725 ||| NNP
cells  ||| S:725 E:731 ||| NNS
in  ||| S:731 E:734 ||| IN
C3H ||| S:734 E:737 ||| CD
/ ||| S:737 E:738 ||| CD
HeN  ||| S:738 E:742 ||| JJ
mice ||| S:742 E:746 ||| NNS
.  ||| S:746 E:748 ||| .
In  ||| S:748 E:751 ||| IN
addition ||| S:751 E:759 ||| NN
,  ||| S:759 E:761 ||| ,
PSG-1  ||| S:761 E:767 ||| NNP
decreased  ||| S:767 E:777 ||| VBD
the  ||| S:777 E:781 ||| DT
tumor  ||| S:781 E:787 ||| NN
weight  ||| S:787 E:794 ||| NN
and  ||| S:794 E:798 ||| CC
increased  ||| S:798 E:808 ||| VBD
the  ||| S:808 E:812 ||| DT
apoptosis  ||| S:812 E:822 ||| JJ
rate  ||| S:822 E:827 ||| NN
and  ||| S:827 E:831 ||| CC
caspase-3  ||| S:831 E:841 ||| NNP
and  ||| S:841 E:845 ||| CC
caspase-9  ||| S:845 E:855 ||| CD
activities  ||| S:855 E:866 ||| NNS
of  ||| S:866 E:869 ||| IN
tumor  ||| S:869 E:875 ||| NN
derived  ||| S:875 E:883 ||| VBN
from  ||| S:883 E:888 ||| IN
the  ||| S:888 E:892 ||| DT
C3H ||| S:892 E:895 ||| CD
/ ||| S:895 E:896 ||| CD
HeN  ||| S:896 E:900 ||| JJ
mice ||| S:900 E:904 ||| NNS
.  ||| S:904 E:906 ||| .
However ||| S:906 E:913 ||| RB
,  ||| S:913 E:915 ||| ,
none  ||| S:915 E:920 ||| NN
of  ||| S:920 E:923 ||| IN
these  ||| S:923 E:929 ||| DT
activities  ||| S:929 E:940 ||| NNS
were  ||| S:940 E:945 ||| VBD
observed  ||| S:945 E:954 ||| VBN
in  ||| S:954 E:957 ||| IN
C3H ||| S:957 E:960 ||| CD
/ ||| S:960 E:961 ||| CD
HeJ  ||| S:961 E:965 ||| JJ
mice ||| S:965 E:969 ||| NNS
.  ||| S:969 E:971 ||| .
In  ||| S:971 E:974 ||| IN
summary ||| S:974 E:981 ||| NN
,  ||| S:981 E:983 ||| ,
these  ||| S:983 E:989 ||| DT
findings  ||| S:989 E:998 ||| NNS
demonstrated  ||| S:998 E:1011 ||| VBN
that  ||| S:1011 E:1016 ||| IN
the  ||| S:1016 E:1020 ||| DT
antitumor  ||| S:1020 E:1030 ||| JJ
activity  ||| S:1030 E:1039 ||| NN
of  ||| S:1039 E:1042 ||| IN
PSG-1  ||| S:1042 E:1048 ||| NNP
is  ||| S:1048 E:1051 ||| VBZ
mediated  ||| S:1051 E:1060 ||| VBN
by  ||| S:1060 E:1063 ||| IN
TLR4 ||| S:1063 E:1067 ||| CD
.  ||| S:1067 E:1069 ||| .
